| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abruptio Placentae | 28 | 2021 | 118 | 10.450 |
Why?
|
| Pregnancy Complications | 77 | 2022 | 2861 | 9.240 |
Why?
|
| Diabetes, Gestational | 52 | 2023 | 1184 | 7.150 |
Why?
|
| Pre-Eclampsia | 59 | 2023 | 1200 | 6.270 |
Why?
|
| Pregnant Women | 28 | 2022 | 568 | 6.250 |
Why?
|
| Pregnancy | 266 | 2023 | 29144 | 5.460 |
Why?
|
| Peru | 63 | 2022 | 881 | 5.400 |
Why?
|
| Suicidal Ideation | 19 | 2022 | 1248 | 4.250 |
Why?
|
| Spouse Abuse | 14 | 2018 | 178 | 4.120 |
Why?
|
| Migraine Disorders | 30 | 2021 | 1620 | 3.730 |
Why?
|
| Adult Survivors of Child Abuse | 9 | 2019 | 260 | 2.920 |
Why?
|
| Birth Weight | 25 | 2019 | 2069 | 2.910 |
Why?
|
| Premature Birth | 23 | 2021 | 1721 | 2.760 |
Why?
|
| Washington | 39 | 2018 | 313 | 2.650 |
Why?
|
| Stress, Psychological | 20 | 2019 | 4245 | 2.580 |
Why?
|
| Depression | 33 | 2022 | 7766 | 2.510 |
Why?
|
| Students | 15 | 2020 | 1654 | 2.300 |
Why?
|
| Hair | 6 | 2023 | 483 | 2.220 |
Why?
|
| Body Mass Index | 59 | 2022 | 12720 | 2.200 |
Why?
|
| Adult | 292 | 2022 | 214055 | 2.200 |
Why?
|
| Placenta | 15 | 2023 | 1698 | 2.060 |
Why?
|
| Hydrocortisone | 8 | 2023 | 1826 | 2.060 |
Why?
|
| Gestational Age | 30 | 2019 | 3493 | 2.010 |
Why?
|
| Female | 363 | 2023 | 380194 | 1.980 |
Why?
|
| Young Adult | 123 | 2021 | 56430 | 1.920 |
Why?
|
| Odds Ratio | 58 | 2019 | 9849 | 1.890 |
Why?
|
| Pregnancy Trimester, First | 18 | 2021 | 853 | 1.840 |
Why?
|
| Depression, Postpartum | 7 | 2019 | 340 | 1.830 |
Why?
|
| Pregnancy Outcome | 28 | 2019 | 2795 | 1.810 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 9 | 2016 | 1004 | 1.800 |
Why?
|
| DNA, Mitochondrial | 5 | 2017 | 817 | 1.790 |
Why?
|
| Sleep | 16 | 2022 | 4623 | 1.730 |
Why?
|
| Battered Women | 7 | 2015 | 36 | 1.720 |
Why?
|
| Depressive Disorder | 13 | 2018 | 3748 | 1.720 |
Why?
|
| Risk Factors | 152 | 2022 | 72290 | 1.690 |
Why?
|
| Cross-Sectional Studies | 81 | 2022 | 25043 | 1.690 |
Why?
|
| Disabled Children | 4 | 2015 | 247 | 1.690 |
Why?
|
| Physical Exertion | 4 | 2019 | 695 | 1.670 |
Why?
|
| Snoring | 4 | 2017 | 191 | 1.610 |
Why?
|
| Child Abuse | 6 | 2017 | 1030 | 1.550 |
Why?
|
| Prevalence | 58 | 2021 | 15226 | 1.530 |
Why?
|
| Ethiopia | 22 | 2018 | 495 | 1.500 |
Why?
|
| Obesity | 40 | 2022 | 12745 | 1.460 |
Why?
|
| Maternal Age | 22 | 2017 | 802 | 1.440 |
Why?
|
| Humans | 388 | 2024 | 744343 | 1.430 |
Why?
|
| Anxiety Disorders | 11 | 2022 | 2690 | 1.430 |
Why?
|
| Obstetric Labor, Premature | 7 | 2014 | 279 | 1.380 |
Why?
|
| Stillbirth | 5 | 2019 | 346 | 1.380 |
Why?
|
| Child Abuse, Sexual | 4 | 2015 | 383 | 1.370 |
Why?
|
| Logistic Models | 51 | 2022 | 13408 | 1.320 |
Why?
|
| Thailand | 15 | 2015 | 296 | 1.320 |
Why?
|
| Case-Control Studies | 69 | 2019 | 21746 | 1.320 |
Why?
|
| Socioeconomic Factors | 39 | 2021 | 7785 | 1.290 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2021 | 4266 | 1.250 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 604 | 1.250 |
Why?
|
| Suicide, Attempted | 5 | 2019 | 1221 | 1.240 |
Why?
|
| Cadmium | 4 | 2018 | 212 | 1.230 |
Why?
|
| Overweight | 18 | 2019 | 2371 | 1.210 |
Why?
|
| Hypertension | 16 | 2023 | 8480 | 1.150 |
Why?
|
| Fetal Membranes, Premature Rupture | 7 | 2018 | 140 | 1.140 |
Why?
|
| Adolescent | 81 | 2021 | 85781 | 1.100 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 238 | 1.100 |
Why?
|
| Glucose Intolerance | 5 | 2017 | 577 | 1.070 |
Why?
|
| Weight Gain | 12 | 2016 | 2292 | 1.070 |
Why?
|
| Placentation | 4 | 2023 | 82 | 1.060 |
Why?
|
| Blood Pressure | 17 | 2019 | 8554 | 1.050 |
Why?
|
| Prenatal Care | 11 | 2017 | 1092 | 1.020 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 570 | 1.020 |
Why?
|
| Pregnancy Trimester, Second | 11 | 2019 | 732 | 1.000 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2016 | 227 | 0.990 |
Why?
|
| Mothers | 11 | 2021 | 2165 | 0.990 |
Why?
|
| Cohort Studies | 61 | 2019 | 40561 | 0.970 |
Why?
|
| Prospective Studies | 81 | 2021 | 53288 | 0.960 |
Why?
|
| Maternal Exposure | 6 | 2018 | 961 | 0.960 |
Why?
|
| Menarche | 3 | 2015 | 516 | 0.950 |
Why?
|
| Fetal Development | 7 | 2016 | 767 | 0.950 |
Why?
|
| Anger | 4 | 2019 | 402 | 0.940 |
Why?
|
| Pregnancy Trimesters | 5 | 2015 | 192 | 0.930 |
Why?
|
| Perinatal Care | 4 | 2018 | 227 | 0.930 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 7 | 2016 | 378 | 0.910 |
Why?
|
| Universities | 7 | 2020 | 956 | 0.890 |
Why?
|
| Infant Mortality | 3 | 2019 | 754 | 0.880 |
Why?
|
| Health Behavior | 7 | 2019 | 2636 | 0.850 |
Why?
|
| Glucose Tolerance Test | 8 | 2018 | 1150 | 0.850 |
Why?
|
| Psychometrics | 11 | 2022 | 3002 | 0.840 |
Why?
|
| Social Support | 5 | 2020 | 2118 | 0.820 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2017 | 500 | 0.820 |
Why?
|
| Health Surveys | 10 | 2019 | 4037 | 0.820 |
Why?
|
| Confidence Intervals | 16 | 2015 | 2971 | 0.820 |
Why?
|
| Anxiety | 7 | 2022 | 4297 | 0.810 |
Why?
|
| Circadian Rhythm | 6 | 2022 | 2624 | 0.810 |
Why?
|
| Violence | 3 | 2017 | 909 | 0.800 |
Why?
|
| Sex Offenses | 3 | 2017 | 354 | 0.800 |
Why?
|
| C-Reactive Protein | 7 | 2017 | 3778 | 0.780 |
Why?
|
| Gene Dosage | 3 | 2015 | 1252 | 0.770 |
Why?
|
| Women's Health | 7 | 2022 | 2034 | 0.770 |
Why?
|
| Genomic Imprinting | 2 | 2020 | 328 | 0.760 |
Why?
|
| Sleep Deprivation | 5 | 2015 | 832 | 0.750 |
Why?
|
| Body Weight | 12 | 2019 | 4669 | 0.750 |
Why?
|
| Uterine Hemorrhage | 2 | 2016 | 255 | 0.750 |
Why?
|
| Vitamin D | 9 | 2016 | 3223 | 0.750 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2015 | 489 | 0.740 |
Why?
|
| Smoking | 19 | 2017 | 8987 | 0.730 |
Why?
|
| Life Style | 13 | 2017 | 3835 | 0.730 |
Why?
|
| Caregivers | 4 | 2015 | 2094 | 0.730 |
Why?
|
| Natural Language Processing | 2 | 2018 | 1041 | 0.730 |
Why?
|
| Occupations | 4 | 2013 | 517 | 0.710 |
Why?
|
| Chile | 7 | 2022 | 237 | 0.710 |
Why?
|
| Blood Pressure Determination | 4 | 2015 | 634 | 0.700 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2014 | 712 | 0.700 |
Why?
|
| Developing Countries | 5 | 2016 | 2815 | 0.700 |
Why?
|
| Menstrual Cycle | 3 | 2023 | 551 | 0.700 |
Why?
|
| Ecosystem | 1 | 2024 | 474 | 0.690 |
Why?
|
| Mass Screening | 8 | 2018 | 5255 | 0.690 |
Why?
|
| Caffeine | 3 | 2013 | 699 | 0.690 |
Why?
|
| Vitamin D Deficiency | 5 | 2015 | 1343 | 0.680 |
Why?
|
| Domestic Violence | 3 | 2010 | 176 | 0.680 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2018 | 571 | 0.660 |
Why?
|
| Depressive Disorder, Major | 7 | 2016 | 4644 | 0.660 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 3923 | 0.660 |
Why?
|
| Life Change Events | 3 | 2015 | 938 | 0.660 |
Why?
|
| Infant, Newborn | 35 | 2021 | 25625 | 0.660 |
Why?
|
| Motor Activity | 9 | 2017 | 2714 | 0.660 |
Why?
|
| Cross-Cultural Comparison | 5 | 2015 | 651 | 0.650 |
Why?
|
| Mental Disorders | 7 | 2022 | 6600 | 0.640 |
Why?
|
| Waist Circumference | 5 | 2019 | 917 | 0.640 |
Why?
|
| Oscillometry | 2 | 2015 | 147 | 0.640 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2015 | 944 | 0.640 |
Why?
|
| Infant, Low Birth Weight | 8 | 2019 | 850 | 0.630 |
Why?
|
| Mood Disorders | 4 | 2012 | 1106 | 0.620 |
Why?
|
| Comorbidity | 17 | 2017 | 10388 | 0.610 |
Why?
|
| Prenatal Diagnosis | 4 | 2014 | 1236 | 0.610 |
Why?
|
| Reproducibility of Results | 22 | 2022 | 19905 | 0.610 |
Why?
|
| Saliva | 4 | 2019 | 809 | 0.600 |
Why?
|
| Lipids | 10 | 2017 | 3305 | 0.600 |
Why?
|
| Fetal Blood | 2 | 2014 | 1318 | 0.600 |
Why?
|
| Beverages | 2 | 2013 | 820 | 0.590 |
Why?
|
| Labor, Induced | 1 | 2018 | 146 | 0.580 |
Why?
|
| Blood Glucose | 12 | 2023 | 6256 | 0.580 |
Why?
|
| Male | 114 | 2023 | 350118 | 0.580 |
Why?
|
| Parturition | 2 | 2018 | 441 | 0.580 |
Why?
|
| Maternal Welfare | 5 | 2014 | 115 | 0.580 |
Why?
|
| Insulin Resistance | 4 | 2023 | 3864 | 0.570 |
Why?
|
| Leisure Activities | 6 | 2018 | 311 | 0.570 |
Why?
|
| Family Conflict | 2 | 2015 | 95 | 0.570 |
Why?
|
| Asthma | 6 | 2017 | 6011 | 0.570 |
Why?
|
| Dyslipidemias | 3 | 2017 | 849 | 0.560 |
Why?
|
| Leptin | 6 | 2015 | 1599 | 0.560 |
Why?
|
| Diet | 9 | 2018 | 7939 | 0.550 |
Why?
|
| Fatty Acids, Omega-3 | 8 | 2016 | 1344 | 0.550 |
Why?
|
| Health Status | 5 | 2019 | 4034 | 0.540 |
Why?
|
| Cryptochromes | 1 | 2015 | 45 | 0.540 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 455 | 0.540 |
Why?
|
| Extraembryonic Membranes | 1 | 2015 | 41 | 0.540 |
Why?
|
| Physical Examination | 5 | 2014 | 1237 | 0.530 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 45 | 0.530 |
Why?
|
| Chorion | 1 | 2015 | 117 | 0.530 |
Why?
|
| Urban Population | 5 | 2018 | 2021 | 0.520 |
Why?
|
| Calcium, Dietary | 2 | 2016 | 526 | 0.520 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2022 | 1813 | 0.520 |
Why?
|
| Lipoproteins | 2 | 2015 | 878 | 0.520 |
Why?
|
| Fatigue | 2 | 2014 | 1531 | 0.520 |
Why?
|
| Central Nervous System Stimulants | 3 | 2013 | 1148 | 0.520 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2014 | 424 | 0.520 |
Why?
|
| Psychotic Disorders | 3 | 2019 | 3046 | 0.510 |
Why?
|
| Periodontal Diseases | 2 | 2009 | 449 | 0.510 |
Why?
|
| Risk | 20 | 2017 | 9687 | 0.510 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 98 | 0.510 |
Why?
|
| Mitochondria | 3 | 2018 | 3520 | 0.510 |
Why?
|
| Factor Analysis, Statistical | 6 | 2018 | 977 | 0.510 |
Why?
|
| Organ Size | 4 | 2015 | 2252 | 0.510 |
Why?
|
| Middle Aged | 65 | 2020 | 213383 | 0.510 |
Why?
|
| Occupational Medicine | 2 | 2012 | 115 | 0.510 |
Why?
|
| Cross-Over Studies | 6 | 2019 | 2029 | 0.510 |
Why?
|
| Exercise | 11 | 2018 | 5615 | 0.500 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2014 | 548 | 0.490 |
Why?
|
| Cesarean Section | 2 | 2018 | 1365 | 0.480 |
Why?
|
| Amnion | 1 | 2015 | 209 | 0.480 |
Why?
|
| Parity | 8 | 2014 | 929 | 0.480 |
Why?
|
| Fasting | 3 | 2015 | 1593 | 0.480 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2017 | 6038 | 0.480 |
Why?
|
| Pyruvates | 1 | 2014 | 87 | 0.480 |
Why?
|
| Pilot Projects | 12 | 2021 | 8324 | 0.480 |
Why?
|
| Sex Factors | 21 | 2019 | 10397 | 0.480 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2014 | 87 | 0.470 |
Why?
|
| International Cooperation | 1 | 2020 | 1420 | 0.470 |
Why?
|
| Minority Groups | 2 | 2021 | 1223 | 0.470 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 867 | 0.470 |
Why?
|
| Child | 35 | 2022 | 77709 | 0.470 |
Why?
|
| Self Report | 6 | 2017 | 3558 | 0.470 |
Why?
|
| Migraine without Aura | 1 | 2014 | 83 | 0.470 |
Why?
|
| Iron, Dietary | 2 | 2011 | 141 | 0.460 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2021 | 15519 | 0.460 |
Why?
|
| Metals | 1 | 2018 | 719 | 0.460 |
Why?
|
| Allostasis | 1 | 2014 | 70 | 0.460 |
Why?
|
| Recreation | 5 | 2008 | 115 | 0.460 |
Why?
|
| Physical Fitness | 4 | 2022 | 733 | 0.450 |
Why?
|
| Actigraphy | 2 | 2015 | 488 | 0.440 |
Why?
|
| Thinness | 3 | 2014 | 480 | 0.430 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 456 | 0.430 |
Why?
|
| Multivariate Analysis | 13 | 2016 | 12245 | 0.430 |
Why?
|
| Body Height | 4 | 2016 | 1577 | 0.430 |
Why?
|
| Needs Assessment | 2 | 2018 | 1147 | 0.430 |
Why?
|
| MicroRNAs | 5 | 2018 | 3752 | 0.430 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2006 | 707 | 0.430 |
Why?
|
| Gene Expression | 5 | 2015 | 7799 | 0.420 |
Why?
|
| Migraine with Aura | 1 | 2014 | 203 | 0.420 |
Why?
|
| Sexual Partners | 3 | 2013 | 730 | 0.420 |
Why?
|
| Malus | 2 | 2022 | 48 | 0.420 |
Why?
|
| Interviews as Topic | 9 | 2017 | 2539 | 0.420 |
Why?
|
| Atherosclerosis | 4 | 2017 | 3445 | 0.420 |
Why?
|
| Coercion | 2 | 2009 | 63 | 0.420 |
Why?
|
| Registries | 8 | 2021 | 8089 | 0.410 |
Why?
|
| Pandemics | 8 | 2024 | 8388 | 0.410 |
Why?
|
| Postpartum Period | 3 | 2015 | 1086 | 0.410 |
Why?
|
| Northwestern United States | 3 | 2018 | 20 | 0.410 |
Why?
|
| DNA Damage | 2 | 2013 | 2432 | 0.410 |
Why?
|
| Cardiovascular Diseases | 12 | 2021 | 15165 | 0.410 |
Why?
|
| Unemployment | 1 | 2013 | 214 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2021 | 17446 | 0.410 |
Why?
|
| Achievement | 1 | 2013 | 291 | 0.410 |
Why?
|
| Homocysteine | 2 | 2006 | 647 | 0.410 |
Why?
|
| Epidemiology | 1 | 2014 | 287 | 0.400 |
Why?
|
| Environmental Exposure | 5 | 2021 | 4234 | 0.400 |
Why?
|
| Triglycerides | 10 | 2019 | 2454 | 0.400 |
Why?
|
| Mental Health | 6 | 2021 | 3019 | 0.400 |
Why?
|
| Electronic Health Records | 2 | 2018 | 4468 | 0.400 |
Why?
|
| Environmental Pollutants | 2 | 2018 | 1179 | 0.400 |
Why?
|
| Age Distribution | 6 | 2018 | 2902 | 0.400 |
Why?
|
| Seasons | 4 | 2023 | 1493 | 0.390 |
Why?
|
| Waist-Hip Ratio | 2 | 2018 | 517 | 0.390 |
Why?
|
| Parabens | 3 | 2017 | 108 | 0.380 |
Why?
|
| Dyssomnias | 1 | 2010 | 29 | 0.380 |
Why?
|
| Adiposity | 4 | 2022 | 1807 | 0.380 |
Why?
|
| Regression Analysis | 6 | 2017 | 6459 | 0.380 |
Why?
|
| Social Class | 1 | 2019 | 1999 | 0.370 |
Why?
|
| Cholesterol, Dietary | 1 | 2011 | 231 | 0.370 |
Why?
|
| Anthropometry | 4 | 2019 | 1350 | 0.370 |
Why?
|
| Adiponectin | 5 | 2015 | 1100 | 0.370 |
Why?
|
| United States | 26 | 2024 | 69872 | 0.370 |
Why?
|
| Heme | 2 | 2011 | 307 | 0.370 |
Why?
|
| Self-Injurious Behavior | 1 | 2015 | 465 | 0.360 |
Why?
|
| Risk Assessment | 20 | 2021 | 23338 | 0.360 |
Why?
|
| Interpersonal Relations | 4 | 2019 | 1425 | 0.360 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 381 | 0.360 |
Why?
|
| New Zealand | 7 | 2019 | 355 | 0.360 |
Why?
|
| Gastroschisis | 1 | 2011 | 97 | 0.360 |
Why?
|
| Trachoma | 1 | 2009 | 29 | 0.360 |
Why?
|
| Checklist | 1 | 2017 | 833 | 0.360 |
Why?
|
| Hyperglycemia | 3 | 2023 | 1373 | 0.350 |
Why?
|
| Toilet Facilities | 1 | 2009 | 26 | 0.350 |
Why?
|
| DNA Methylation | 4 | 2018 | 4286 | 0.350 |
Why?
|
| Eggs | 1 | 2011 | 184 | 0.350 |
Why?
|
| Metabolome | 1 | 2016 | 895 | 0.350 |
Why?
|
| Body Composition | 4 | 2019 | 2401 | 0.350 |
Why?
|
| Seafood | 3 | 2018 | 384 | 0.340 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.330 |
Why?
|
| Harm Reduction | 1 | 2010 | 129 | 0.330 |
Why?
|
| Lactic Acid | 1 | 2014 | 1133 | 0.330 |
Why?
|
| Suicide | 2 | 2017 | 1477 | 0.330 |
Why?
|
| Telomere | 1 | 2015 | 910 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2018 | 2408 | 0.320 |
Why?
|
| Eligibility Determination | 1 | 2012 | 403 | 0.320 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1941 | 0.320 |
Why?
|
| Vaccination | 1 | 2020 | 3278 | 0.320 |
Why?
|
| Age Factors | 12 | 2017 | 18370 | 0.320 |
Why?
|
| Vitamins | 2 | 2015 | 1622 | 0.320 |
Why?
|
| Outpatients | 1 | 2016 | 1486 | 0.310 |
Why?
|
| Cystatins | 1 | 2008 | 55 | 0.310 |
Why?
|
| Water Supply | 1 | 2009 | 214 | 0.310 |
Why?
|
| Perception | 1 | 2014 | 1198 | 0.310 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3133 | 0.310 |
Why?
|
| Abortion, Spontaneous | 2 | 2003 | 544 | 0.310 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3240 | 0.310 |
Why?
|
| Hospitalization | 3 | 2018 | 10262 | 0.300 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 234 | 0.300 |
Why?
|
| Health Care Rationing | 2 | 2021 | 437 | 0.300 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2019 | 440 | 0.300 |
Why?
|
| Time Factors | 15 | 2021 | 40075 | 0.300 |
Why?
|
| Dibutyl Phthalate | 2 | 2017 | 30 | 0.300 |
Why?
|
| Aggression | 2 | 2009 | 753 | 0.300 |
Why?
|
| Abortion, Induced | 2 | 2003 | 458 | 0.300 |
Why?
|
| Spain | 3 | 2019 | 465 | 0.300 |
Why?
|
| Aging | 2 | 2020 | 8664 | 0.290 |
Why?
|
| Models, Statistical | 2 | 2020 | 5102 | 0.290 |
Why?
|
| Shellfish | 2 | 2018 | 38 | 0.290 |
Why?
|
| Quality of Life | 7 | 2022 | 12804 | 0.290 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 522 | 0.290 |
Why?
|
| Dietary Fiber | 2 | 2008 | 760 | 0.290 |
Why?
|
| Pregnancy, Unplanned | 1 | 2007 | 95 | 0.290 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1411 | 0.280 |
Why?
|
| Incidence | 12 | 2021 | 20947 | 0.280 |
Why?
|
| Leukocytes | 1 | 2015 | 2043 | 0.280 |
Why?
|
| Fetal Death | 3 | 2015 | 448 | 0.280 |
Why?
|
| Epidemiologic Studies | 4 | 2016 | 676 | 0.280 |
Why?
|
| Malondialdehyde | 1 | 2006 | 105 | 0.280 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2005 | 123 | 0.280 |
Why?
|
| Fetal Macrosomia | 3 | 2018 | 124 | 0.270 |
Why?
|
| Fatty Acids | 1 | 2014 | 1809 | 0.270 |
Why?
|
| Reproduction | 1 | 2011 | 668 | 0.270 |
Why?
|
| Metabolic Diseases | 3 | 2019 | 658 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2018 | 6544 | 0.270 |
Why?
|
| World Health Organization | 3 | 2020 | 1318 | 0.270 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 3022 | 0.270 |
Why?
|
| Yoga | 2 | 2020 | 253 | 0.270 |
Why?
|
| Language | 2 | 2018 | 1471 | 0.260 |
Why?
|
| Morbidity | 1 | 2011 | 1769 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 11725 | 0.260 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2023 | 703 | 0.260 |
Why?
|
| Body Burden | 2 | 2016 | 158 | 0.260 |
Why?
|
| Peer Group | 1 | 2010 | 635 | 0.260 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2057 | 0.250 |
Why?
|
| Self Concept | 2 | 2008 | 1025 | 0.250 |
Why?
|
| Alcohol Drinking | 4 | 2011 | 3966 | 0.250 |
Why?
|
| Hemodynamics | 1 | 2015 | 4199 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2400 | 0.250 |
Why?
|
| Preventive Medicine | 1 | 2006 | 264 | 0.250 |
Why?
|
| Genome-Wide Association Study | 6 | 2021 | 12261 | 0.240 |
Why?
|
| Linear Models | 8 | 2015 | 5952 | 0.240 |
Why?
|
| Diabetes Mellitus | 6 | 2016 | 5751 | 0.240 |
Why?
|
| Periodicity | 1 | 2005 | 363 | 0.240 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 906 | 0.240 |
Why?
|
| C-Peptide | 1 | 2005 | 419 | 0.240 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3086 | 0.240 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 124 | 0.230 |
Why?
|
| Hyperuricemia | 1 | 2006 | 211 | 0.230 |
Why?
|
| Psychotropic Drugs | 1 | 2009 | 894 | 0.230 |
Why?
|
| Lipase | 1 | 2005 | 314 | 0.230 |
Why?
|
| Educational Status | 4 | 2015 | 2540 | 0.220 |
Why?
|
| Population Surveillance | 4 | 2019 | 2616 | 0.220 |
Why?
|
| Medical Oncology | 1 | 2015 | 2265 | 0.220 |
Why?
|
| Cholesterol, HDL | 6 | 2006 | 1814 | 0.220 |
Why?
|
| Medical History Taking | 2 | 2018 | 783 | 0.220 |
Why?
|
| Databases, Factual | 5 | 2019 | 7729 | 0.220 |
Why?
|
| Health Status Disparities | 5 | 2020 | 1797 | 0.220 |
Why?
|
| ROC Curve | 3 | 2016 | 3527 | 0.220 |
Why?
|
| Causality | 3 | 2015 | 1275 | 0.210 |
Why?
|
| Longitudinal Studies | 11 | 2021 | 13989 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1676 | 0.210 |
Why?
|
| Menorrhagia | 1 | 2022 | 63 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2020 | 0.210 |
Why?
|
| Federal Government | 1 | 2024 | 260 | 0.210 |
Why?
|
| Occupational Health | 2 | 2013 | 809 | 0.210 |
Why?
|
| Asia, Southeastern | 2 | 2012 | 111 | 0.210 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 3843 | 0.210 |
Why?
|
| Motivation | 2 | 2020 | 1971 | 0.200 |
Why?
|
| Reproductive History | 1 | 2003 | 209 | 0.200 |
Why?
|
| Primary Prevention | 2 | 2021 | 1167 | 0.200 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 15540 | 0.200 |
Why?
|
| Catha | 2 | 2013 | 9 | 0.200 |
Why?
|
| Pregnancy, High-Risk | 3 | 2014 | 120 | 0.200 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 940 | 0.200 |
Why?
|
| Fetal Distress | 2 | 2018 | 40 | 0.190 |
Why?
|
| Africa South of the Sahara | 2 | 2015 | 724 | 0.190 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2015 | 361 | 0.190 |
Why?
|
| Uric Acid | 1 | 2006 | 766 | 0.190 |
Why?
|
| Interview, Psychological | 2 | 2015 | 812 | 0.190 |
Why?
|
| Mental Health Services | 1 | 2012 | 1643 | 0.190 |
Why?
|
| Cytokines | 3 | 2021 | 7322 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2005 | 2015 | 0.190 |
Why?
|
| Polysomnography | 3 | 2015 | 1776 | 0.180 |
Why?
|
| Engineering | 1 | 2020 | 58 | 0.180 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 434 | 0.180 |
Why?
|
| Carotenoids | 1 | 2003 | 624 | 0.180 |
Why?
|
| Carboxyhemoglobin | 2 | 2010 | 81 | 0.180 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.180 |
Why?
|
| Propylthiouracil | 1 | 2019 | 69 | 0.180 |
Why?
|
| Focus Groups | 2 | 2015 | 1321 | 0.180 |
Why?
|
| Erythrocytes | 2 | 2006 | 2455 | 0.180 |
Why?
|
| Ferritins | 1 | 2002 | 590 | 0.180 |
Why?
|
| Fishes | 2 | 2017 | 569 | 0.180 |
Why?
|
| Magnesium | 2 | 2018 | 813 | 0.170 |
Why?
|
| Glucose | 1 | 2012 | 4397 | 0.170 |
Why?
|
| Famous Persons | 1 | 2020 | 108 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 2007 | 0.170 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 1151 | 0.170 |
Why?
|
| Infant | 10 | 2019 | 35136 | 0.170 |
Why?
|
| Vietnam | 2 | 2012 | 408 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3158 | 0.170 |
Why?
|
| Family Practice | 1 | 2002 | 516 | 0.170 |
Why?
|
| Mesalamine | 2 | 2017 | 136 | 0.170 |
Why?
|
| Genetic Loci | 2 | 2019 | 2575 | 0.170 |
Why?
|
| Mathematics | 1 | 2020 | 728 | 0.170 |
Why?
|
| Counseling | 3 | 2015 | 1523 | 0.170 |
Why?
|
| Lectins | 1 | 2021 | 513 | 0.170 |
Why?
|
| Vitamin E | 1 | 2003 | 869 | 0.170 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 1917 | 0.160 |
Why?
|
| Lactobacillus | 1 | 2019 | 189 | 0.160 |
Why?
|
| Medicaid | 1 | 2012 | 2736 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 252 | 0.160 |
Why?
|
| Population Groups | 2 | 2017 | 209 | 0.160 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5137 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2015 | 1534 | 0.160 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 370 | 0.160 |
Why?
|
| Molybdenum | 1 | 2018 | 46 | 0.160 |
Why?
|
| Sperm Motility | 2 | 2016 | 253 | 0.160 |
Why?
|
| Taste | 1 | 2019 | 176 | 0.160 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 2187 | 0.160 |
Why?
|
| Puerperal Disorders | 2 | 2018 | 275 | 0.160 |
Why?
|
| Technology | 1 | 2020 | 305 | 0.160 |
Why?
|
| Electric Countershock | 1 | 2021 | 534 | 0.160 |
Why?
|
| Georgia (Republic) | 2 | 2007 | 41 | 0.160 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 29 | 0.160 |
Why?
|
| Leukemia | 1 | 2006 | 1511 | 0.160 |
Why?
|
| China | 2 | 2014 | 2248 | 0.150 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4328 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 73 | 0.150 |
Why?
|
| Fetus | 2 | 2020 | 1880 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 2019 | 245 | 0.150 |
Why?
|
| Translating | 2 | 2016 | 144 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 47 | 0.150 |
Why?
|
| Science | 1 | 2020 | 241 | 0.150 |
Why?
|
| Endocrine Glands | 1 | 2017 | 103 | 0.150 |
Why?
|
| Health Priorities | 1 | 2020 | 380 | 0.150 |
Why?
|
| Marriage | 1 | 2019 | 339 | 0.150 |
Why?
|
| Carbon Monoxide | 2 | 2011 | 531 | 0.150 |
Why?
|
| Solanum tuberosum | 1 | 2017 | 37 | 0.150 |
Why?
|
| Meditation | 1 | 2020 | 242 | 0.150 |
Why?
|
| Databases, Bibliographic | 1 | 2017 | 128 | 0.150 |
Why?
|
| Chronobiology Disorders | 1 | 2018 | 74 | 0.150 |
Why?
|
| Heart Rate | 3 | 2017 | 4091 | 0.150 |
Why?
|
| Psychological Theory | 2 | 2018 | 168 | 0.150 |
Why?
|
| Boston | 3 | 2014 | 9313 | 0.150 |
Why?
|
| Sweden | 3 | 2015 | 1345 | 0.140 |
Why?
|
| Aged | 18 | 2021 | 163280 | 0.140 |
Why?
|
| Zimbabwe | 3 | 2007 | 129 | 0.140 |
Why?
|
| Air Pollutants | 3 | 2021 | 2817 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 339 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2740 | 0.140 |
Why?
|
| Hazardous Substances | 1 | 2017 | 149 | 0.140 |
Why?
|
| Fertilization | 3 | 2022 | 196 | 0.140 |
Why?
|
| Cosmetics | 1 | 2017 | 97 | 0.140 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2016 | 46 | 0.140 |
Why?
|
| Walking | 3 | 2018 | 1180 | 0.140 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 481 | 0.140 |
Why?
|
| Air Pollution | 2 | 2021 | 2286 | 0.140 |
Why?
|
| Medical Records | 3 | 2007 | 1413 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 954 | 0.140 |
Why?
|
| Ascorbic Acid | 3 | 2004 | 651 | 0.140 |
Why?
|
| Iceland | 1 | 2016 | 183 | 0.140 |
Why?
|
| Epicardial Mapping | 1 | 2015 | 57 | 0.140 |
Why?
|
| Vegetables | 2 | 2019 | 1182 | 0.130 |
Why?
|
| Siblings | 2 | 2015 | 854 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 2 | 2023 | 553 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3188 | 0.130 |
Why?
|
| Food Preferences | 1 | 2019 | 399 | 0.130 |
Why?
|
| Phthalic Acids | 2 | 2017 | 436 | 0.130 |
Why?
|
| Central Venous Pressure | 1 | 2015 | 78 | 0.130 |
Why?
|
| Preconception Care | 2 | 2007 | 134 | 0.130 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2015 | 31 | 0.130 |
Why?
|
| Antioxidants | 1 | 2003 | 1663 | 0.130 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2015 | 149 | 0.130 |
Why?
|
| Selenium | 1 | 2018 | 405 | 0.130 |
Why?
|
| House Calls | 1 | 2017 | 160 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3870 | 0.130 |
Why?
|
| Maternal Behavior | 1 | 2017 | 311 | 0.130 |
Why?
|
| Social Behavior | 2 | 2019 | 1127 | 0.130 |
Why?
|
| Chickens | 1 | 2017 | 865 | 0.130 |
Why?
|
| Arsenic | 1 | 2018 | 328 | 0.130 |
Why?
|
| Prehypertension | 1 | 2015 | 61 | 0.130 |
Why?
|
| Alabama | 1 | 2015 | 98 | 0.130 |
Why?
|
| Statistics as Topic | 4 | 2012 | 2373 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1889 | 0.130 |
Why?
|
| Decidua | 1 | 2015 | 86 | 0.130 |
Why?
|
| Supine Position | 1 | 2015 | 205 | 0.130 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 188 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 1504 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2020 | 680 | 0.130 |
Why?
|
| Health Services, Indigenous | 1 | 2015 | 42 | 0.120 |
Why?
|
| History, Ancient | 1 | 2015 | 212 | 0.120 |
Why?
|
| Carcinoid Tumor | 1 | 2016 | 235 | 0.120 |
Why?
|
| Estriol | 1 | 2014 | 53 | 0.120 |
Why?
|
| Genotype | 3 | 2016 | 12951 | 0.120 |
Why?
|
| Telemetry | 1 | 2016 | 205 | 0.120 |
Why?
|
| Endometriosis | 1 | 2022 | 839 | 0.120 |
Why?
|
| Immune System | 1 | 2020 | 805 | 0.120 |
Why?
|
| Vagina | 1 | 2019 | 825 | 0.120 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 258 | 0.120 |
Why?
|
| Secretory Rate | 1 | 2014 | 82 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1572 | 0.120 |
Why?
|
| Cholesterol | 5 | 2006 | 2917 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3647 | 0.120 |
Why?
|
| Metabolomics | 3 | 2019 | 1484 | 0.120 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 468 | 0.120 |
Why?
|
| Semen | 1 | 2016 | 316 | 0.120 |
Why?
|
| Social Environment | 2 | 2021 | 1023 | 0.120 |
Why?
|
| Politics | 1 | 2020 | 791 | 0.120 |
Why?
|
| Greece | 1 | 2014 | 344 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2016 | 359 | 0.120 |
Why?
|
| Delphi Technique | 1 | 2017 | 778 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.120 |
Why?
|
| Zinc | 1 | 2018 | 684 | 0.120 |
Why?
|
| Chromatography, Liquid | 2 | 2014 | 976 | 0.120 |
Why?
|
| Family Characteristics | 2 | 2017 | 1000 | 0.120 |
Why?
|
| Infant, Premature | 3 | 2011 | 2044 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 268 | 0.120 |
Why?
|
| Data Mining | 1 | 2018 | 537 | 0.120 |
Why?
|
| Cultural Competency | 2 | 2017 | 289 | 0.120 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2005 | 264 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 428 | 0.110 |
Why?
|
| Massachusetts | 2 | 2018 | 8663 | 0.110 |
Why?
|
| Atrial Flutter | 1 | 2015 | 263 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 472 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2013 | 142 | 0.110 |
Why?
|
| Rehabilitation | 1 | 2014 | 134 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 271 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1261 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2015 | 171 | 0.110 |
Why?
|
| Somatomedins | 1 | 2013 | 192 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1184 | 0.110 |
Why?
|
| Embryo Implantation | 1 | 2015 | 272 | 0.110 |
Why?
|
| Dizziness | 1 | 2016 | 251 | 0.110 |
Why?
|
| Laos | 1 | 2012 | 29 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 326 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.110 |
Why?
|
| Shock | 1 | 2015 | 318 | 0.110 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 1997 | 0.110 |
Why?
|
| Hospital Mortality | 2 | 2018 | 5317 | 0.110 |
Why?
|
| Patient Participation | 1 | 2002 | 1457 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 6171 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 966 | 0.110 |
Why?
|
| Biological Clocks | 1 | 2015 | 321 | 0.110 |
Why?
|
| Quality Control | 1 | 2015 | 841 | 0.110 |
Why?
|
| Dietary Supplements | 2 | 2016 | 3297 | 0.110 |
Why?
|
| Urban Health | 2 | 2012 | 547 | 0.110 |
Why?
|
| Follow-Up Studies | 10 | 2019 | 39050 | 0.110 |
Why?
|
| Endocrine Disruptors | 1 | 2015 | 237 | 0.110 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 93 | 0.110 |
Why?
|
| Coronary Disease | 1 | 2007 | 6077 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.110 |
Why?
|
| Cambodia | 1 | 2012 | 191 | 0.100 |
Why?
|
| Pyruvaldehyde | 1 | 2012 | 21 | 0.100 |
Why?
|
| Prolactin | 1 | 2014 | 669 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 803 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9438 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 325 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2002 | 1439 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 511 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2429 | 0.100 |
Why?
|
| Hospitals, General | 1 | 2016 | 749 | 0.100 |
Why?
|
| Television | 1 | 2014 | 409 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1738 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 1157 | 0.100 |
Why?
|
| Spermatozoa | 1 | 2015 | 625 | 0.100 |
Why?
|
| Headache | 2 | 2010 | 1226 | 0.100 |
Why?
|
| Meat | 2 | 2011 | 592 | 0.100 |
Why?
|
| Industry | 1 | 2013 | 365 | 0.100 |
Why?
|
| Hematologic Tests | 1 | 2012 | 240 | 0.100 |
Why?
|
| Phenols | 1 | 2015 | 497 | 0.100 |
Why?
|
| Birth Certificates | 1 | 2011 | 67 | 0.100 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 84 | 0.100 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 265 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2016 | 1609 | 0.100 |
Why?
|
| Pain Measurement | 2 | 2022 | 3420 | 0.100 |
Why?
|
| Posture | 1 | 2015 | 958 | 0.100 |
Why?
|
| Denmark | 3 | 2019 | 738 | 0.090 |
Why?
|
| Paternal Age | 1 | 2011 | 84 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2021 | 41006 | 0.090 |
Why?
|
| Postmenopause | 1 | 2019 | 2461 | 0.090 |
Why?
|
| Age of Onset | 1 | 2017 | 3271 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2016 | 15076 | 0.090 |
Why?
|
| Reference Values | 3 | 2014 | 4982 | 0.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1953 | 0.090 |
Why?
|
| Los Angeles | 2 | 2021 | 238 | 0.090 |
Why?
|
| Marital Status | 2 | 2015 | 437 | 0.090 |
Why?
|
| Empathy | 1 | 2015 | 474 | 0.090 |
Why?
|
| Head | 1 | 2016 | 880 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1668 | 0.090 |
Why?
|
| Arginine | 2 | 2012 | 944 | 0.090 |
Why?
|
| Social Perception | 3 | 2009 | 425 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1861 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1364 | 0.090 |
Why?
|
| Headache Disorders | 1 | 2012 | 130 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2015 | 1047 | 0.090 |
Why?
|
| Retrospective Studies | 13 | 2020 | 77449 | 0.090 |
Why?
|
| Arousal | 1 | 2016 | 1165 | 0.090 |
Why?
|
| Spasms, Infantile | 1 | 2013 | 305 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2282 | 0.090 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 1414 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3396 | 0.090 |
Why?
|
| Progesterone | 1 | 2014 | 776 | 0.090 |
Why?
|
| Cultural Characteristics | 2 | 2009 | 262 | 0.090 |
Why?
|
| Hysterectomy | 1 | 2015 | 927 | 0.090 |
Why?
|
| Heart Atria | 1 | 2015 | 1357 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1708 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2013 | 9146 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 144 | 0.080 |
Why?
|
| Arm | 2 | 2015 | 589 | 0.080 |
Why?
|
| Drinking | 1 | 2010 | 197 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7149 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2015 | 1301 | 0.080 |
Why?
|
| Proteins | 1 | 2004 | 6103 | 0.080 |
Why?
|
| RNA | 2 | 2009 | 2749 | 0.080 |
Why?
|
| Particulate Matter | 3 | 2021 | 2530 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 3229 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2114 | 0.080 |
Why?
|
| Netherlands | 3 | 2021 | 2170 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1184 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2016 | 546 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2661 | 0.080 |
Why?
|
| Weight Loss | 2 | 2013 | 2622 | 0.080 |
Why?
|
| Sexual Harassment | 1 | 2009 | 79 | 0.080 |
Why?
|
| HIV Infections | 1 | 2015 | 16718 | 0.080 |
Why?
|
| Cholesterol, LDL | 4 | 2005 | 2356 | 0.080 |
Why?
|
| Japan | 1 | 2012 | 1360 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3508 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1403 | 0.080 |
Why?
|
| New York City | 2 | 2021 | 710 | 0.080 |
Why?
|
| Carcinoma | 1 | 2019 | 2375 | 0.080 |
Why?
|
| Nitrogen Dioxide | 2 | 2021 | 490 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2008 | 110 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1660 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2013 | 787 | 0.070 |
Why?
|
| Lysine | 1 | 2012 | 1007 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2886 | 0.070 |
Why?
|
| Gravidity | 1 | 2006 | 51 | 0.070 |
Why?
|
| Cystatin C | 1 | 2008 | 250 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2008 | 197 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1405 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2011 | 13033 | 0.070 |
Why?
|
| Managed Care Programs | 1 | 2012 | 950 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 592 | 0.070 |
Why?
|
| Demography | 1 | 2011 | 1656 | 0.070 |
Why?
|
| Jaundice, Neonatal | 1 | 2006 | 71 | 0.070 |
Why?
|
| Receptors, Adiponectin | 1 | 2006 | 81 | 0.070 |
Why?
|
| Substance-Related Disorders | 3 | 2013 | 4258 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2015 | 2682 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2013 | 1827 | 0.070 |
Why?
|
| Adenolymphoma | 1 | 2005 | 10 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2788 | 0.070 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 188 | 0.070 |
Why?
|
| Eclampsia | 1 | 2006 | 58 | 0.070 |
Why?
|
| Poverty | 1 | 2017 | 2660 | 0.070 |
Why?
|
| Employment | 1 | 2012 | 1132 | 0.070 |
Why?
|
| Sperm Count | 2 | 2016 | 216 | 0.060 |
Why?
|
| Systole | 1 | 2007 | 958 | 0.060 |
Why?
|
| Diastole | 1 | 2007 | 791 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2008 | 767 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2008 | 690 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2005 | 63 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 365 | 0.060 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 75 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2022 | 1097 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 565 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 360 | 0.060 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2004 | 24 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2203 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2016 | 302 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2576 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2007 | 3279 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4554 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2004 | 216 | 0.060 |
Why?
|
| Pregnancy Proteins | 1 | 2004 | 229 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2005 | 644 | 0.060 |
Why?
|
| Calcifediol | 2 | 2014 | 166 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1316 | 0.060 |
Why?
|
| Benzodiazepines | 1 | 2009 | 1101 | 0.060 |
Why?
|
| Military Personnel | 1 | 2012 | 1133 | 0.060 |
Why?
|
| Interleukin-11 | 1 | 2023 | 63 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2012 | 4217 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2009 | 986 | 0.060 |
Why?
|
| Finland | 2 | 2015 | 602 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 683 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 707 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4253 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 57776 | 0.050 |
Why?
|
| Australia | 2 | 2017 | 1170 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2866 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 972 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 640 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2585 | 0.050 |
Why?
|
| London | 1 | 2002 | 233 | 0.050 |
Why?
|
| Coffee | 1 | 2007 | 578 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.050 |
Why?
|
| North Carolina | 2 | 2013 | 315 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2006 | 582 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2022 | 148 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 298 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14722 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2010 | 2488 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2022 | 380 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2022 | 2187 | 0.050 |
Why?
|
| Seizures | 1 | 2013 | 2859 | 0.050 |
Why?
|
| Data Collection | 2 | 2012 | 3341 | 0.050 |
Why?
|
| Potassium | 1 | 2005 | 1336 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3086 | 0.050 |
Why?
|
| Animals | 7 | 2023 | 168757 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1097 | 0.050 |
Why?
|
| Behavior | 1 | 2003 | 561 | 0.050 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2019 | 32 | 0.050 |
Why?
|
| Security Measures | 1 | 2020 | 77 | 0.050 |
Why?
|
| Professional Practice | 1 | 2002 | 326 | 0.040 |
Why?
|
| Prognosis | 4 | 2016 | 29063 | 0.040 |
Why?
|
| Canada | 2 | 2015 | 2065 | 0.040 |
Why?
|
| Citrulline | 1 | 2019 | 105 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2003 | 1005 | 0.040 |
Why?
|
| Betaine | 1 | 2019 | 87 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 832 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2006 | 875 | 0.040 |
Why?
|
| Androgens | 1 | 2007 | 1281 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 638 | 0.040 |
Why?
|
| Insulin | 3 | 2023 | 6580 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2009 | 1796 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2003 | 694 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 246 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 495 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2005 | 906 | 0.040 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 29 | 0.040 |
Why?
|
| Obstetrics | 1 | 2005 | 658 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 13881 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2019 | 365 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2006 | 880 | 0.040 |
Why?
|
| England | 1 | 2019 | 522 | 0.040 |
Why?
|
| Fast Foods | 1 | 2019 | 197 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1519 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9981 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 63114 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 2026 | 0.040 |
Why?
|
| Fertilization in Vitro | 2 | 2015 | 1284 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5034 | 0.040 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 20 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2020 | 616 | 0.040 |
Why?
|
| Spouses | 1 | 2019 | 286 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2005 | 2440 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2029 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2020 | 811 | 0.030 |
Why?
|
| Atrial Function, Right | 1 | 2015 | 33 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 62 | 0.030 |
Why?
|
| Tilt-Table Test | 1 | 2016 | 78 | 0.030 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2015 | 19 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2018 | 392 | 0.030 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 631 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2924 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 202 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 20822 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 39 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1465 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 204 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12354 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 173 | 0.030 |
Why?
|
| Parents | 2 | 2009 | 3407 | 0.030 |
Why?
|
| Paternal Exposure | 1 | 2015 | 89 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 350 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 513 | 0.030 |
Why?
|
| Career Choice | 1 | 2020 | 744 | 0.030 |
Why?
|
| Government | 1 | 2015 | 165 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2016 | 223 | 0.030 |
Why?
|
| Norway | 1 | 2015 | 448 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2015 | 405 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 10638 | 0.030 |
Why?
|
| Fruit | 1 | 2019 | 1142 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3265 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 425 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4026 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 370 | 0.030 |
Why?
|
| Africa, Eastern | 1 | 2013 | 71 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 1869 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2016 | 324 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 391 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 440 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 414 | 0.030 |
Why?
|
| Hospitals | 1 | 2006 | 3952 | 0.030 |
Why?
|
| Work | 1 | 2013 | 191 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 2416 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12072 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2016 | 604 | 0.030 |
Why?
|
| Developed Countries | 1 | 2015 | 437 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 1799 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2012 | 193 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2015 | 643 | 0.030 |
Why?
|
| Israel | 1 | 2014 | 796 | 0.030 |
Why?
|
| Alleles | 2 | 2016 | 6933 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 845 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 11727 | 0.030 |
Why?
|
| Coma | 1 | 2015 | 475 | 0.030 |
Why?
|
| Phospholipids | 1 | 2015 | 784 | 0.030 |
Why?
|
| Haplotypes | 2 | 2008 | 2779 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 415 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2015 | 686 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 906 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3920 | 0.020 |
Why?
|
| Uterus | 1 | 2015 | 711 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1772 | 0.020 |
Why?
|
| Epigenomics | 1 | 2016 | 903 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 591 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4186 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Arteries | 1 | 2015 | 1119 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2899 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16365 | 0.020 |
Why?
|
| Fertility | 1 | 2015 | 781 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 1725 | 0.020 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2010 | 66 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 804 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 789 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2002 | 3528 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1061 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1806 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4189 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2016 | 880 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6364 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 972 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2703 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 21683 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2014 | 1359 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1199 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23403 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 116 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3584 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18029 | 0.020 |
Why?
|
| Decision Making | 1 | 2020 | 3887 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2309 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 2519 | 0.020 |
Why?
|
| Testosterone | 1 | 2015 | 2420 | 0.020 |
Why?
|
| Biological Factors | 1 | 2005 | 164 | 0.010 |
Why?
|
| Salivary Glands | 1 | 2005 | 229 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2013 | 1916 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 996 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 1912 | 0.010 |
Why?
|
| Adipocytes | 1 | 2010 | 1184 | 0.010 |
Why?
|
| Health Personnel | 1 | 2017 | 3218 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3638 | 0.010 |
Why?
|
| California | 1 | 2007 | 1402 | 0.010 |
Why?
|
| Models, Biological | 2 | 2010 | 9583 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81183 | 0.010 |
Why?
|
| Tryptophan | 1 | 2005 | 478 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 769 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6442 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2425 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5078 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1730 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1081 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2804 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1282 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 3588 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1125 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2013 | 4558 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2012 | 3309 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1782 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1889 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2849 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 7301 | 0.010 |
Why?
|
| Dementia | 1 | 2008 | 2518 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12788 | 0.010 |
Why?
|
| Heart Failure | 1 | 2015 | 10900 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8428 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7880 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9648 | 0.000 |
Why?
|
| Brain | 1 | 2013 | 26385 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12208 | 0.000 |
Why?
|